BCL2 and cancer: In cancer, there is an inhibition of apoptotic pathways (Figure 8) through the up-regulation of anti-apoptotic proteins (Bcl-2) and the downregulation of the pro-apoptotic proteins (Bax), resulting in intrinsic resistance to chemotherapy [119].